← 返回 Skills 市场
Eisas
作者
hanxueyuan
· GitHub ↗
· v1.0.0
· MIT-0
37
总下载
0
收藏
0
当前安装
1
版本数
在 OpenClaw 中安装
/install eisas
功能描述
Japanese pharmaceutical company specializing in CNS and oncology drugs, known for Alzheimer's treatments like Aricept and Leqembi in global markets.
使用说明 (SKILL.md)
Eisai — Advancing Brain Health
历史时间线
- 1941: Eisai Co., Ltd. founded in Tokyo by Takejiro Ueno
- 1960s-70s: Expands into prescription pharmaceuticals
- 1990s: Establishes US subsidiary, begins global expansion
- 2010: Aricept (donepezil) becomes one of the best-selling Alzheimer's drugs ever
- 2019: Lecanemab (Leqembi) receives FDA breakthrough therapy designation for Alzheimer's
- 2023: Leqembi receives full FDA approval — landmark in Alzheimer's treatment
- 2024: Expanding neuroscience pipeline with new molecular entities
商业模式
- Neurology: Alzheimer's, epilepsy, migraine — core therapeutic area
- Oncology: Multiple cancer drug candidates in development
- Vitality: GI and other therapeutic areas
- Global partnerships: Co-development with Biogen (Leqembi)
护城河分析
- Alzheimer's leadership: Leqembi positions Eisai at the forefront of Alzheimer's treatment
- R&D focus: 20%+ of revenue invested in R&D — above industry average
- hPHC philosophy: "human health care" philosophy drives patient-centric drug development
- Strategic partnerships: Biogen collaboration shares risk and accelerates development
关键数据
- Revenue: ¥800B+ (~$5.5B) annually
- Leqembi potential: Blockbuster status expected with $5B+ peak sales estimate
- R&D spend: ¥160B+ annually
- Employees: 11,000+ across 30+ countries
有趣事实
- Eisai's name comes from "Eisai" (衛佐), the founder's belief that medicine should "aid and protect" (衛る 佐ける) people's health — the company motto is "ihl" (integrative innovation for health and life)
- The Aricept-Lecanemab journey spans 30+ years of Alzheimer's research at Eisai, making it one of the longest and most committed pharma efforts in the disease
安全使用建议
This skill appears low-risk from a security perspective because it is only static informational text. As with any reference content, users should independently verify business or medical-market facts before relying on them.
功能分析
Type: OpenClaw Skill
Name: eisas
Version: 1.0.0
The skill bundle contains purely informational content regarding Eisai, a Japanese pharmaceutical company. There is no executable code, shell commands, or instructions that could lead to prompt injection or unauthorized actions in SKILL.md or _meta.json.
能力评估
Purpose & Capability
The artifacts are coherent with an informational research skill about a pharmaceutical company and do not request operational capabilities.
Instruction Scope
The SKILL.md content provides background facts and research context only; it does not instruct the agent to override user intent, call tools, mutate data, or take external actions.
Install Mechanism
There is no install specification, no code files, no required binaries, and no package or script execution.
Credentials
The skill declares no environment variables, credentials, configuration paths, OS restrictions, network access, or local file access.
Persistence & Privilege
No persistence, background behavior, credential use, account access, or privilege requirements are shown in the provided artifacts.
如何使用
- 确保已安装 OpenClaw（本地或 Docker 部署）
- 在对话框中输入安装命令：
/install eisas - 安装完成后，直接呼叫该 Skill 的名称或使用
/eisas触发 - 根据 Skill 的参数说明提供必要输入，即可获得结构化输出
版本历史
v1.0.0
eisas 1.0.0
- Initial release highlighting Eisai as a leading Japanese pharmaceutical company focused on CNS drugs and oncology.
- Includes a historical timeline from founding (1941) to latest neuroscience pipeline updates (2024).
- Outlines business model, key therapeutic areas, and global partnerships (notably with Biogen).
- Presents a moat analysis emphasizing Alzheimer's leadership and substantial R&D investment.
- Shares key figures: revenue, R&D spend, employee count, and Leqembi's market impact.
- Adds notable facts about company philosophy and decades-long Alzheimer’s research commitment.
元数据
常见问题
Eisas 是什么？
Japanese pharmaceutical company specializing in CNS and oncology drugs, known for Alzheimer's treatments like Aricept and Leqembi in global markets. 它是一个面向 Claude Code / OpenClaw 的 AI Agent Skill 插件，目前累计下载 37 次。
如何安装 Eisas？
在 OpenClaw 或 Claude Code 对话框中运行命令「/install eisas」即可一键安装，无需额外配置。
Eisas 是免费的吗？
是的，Eisas 完全免费，采用 MIT-0 许可证，可自由下载、安装和使用。
Eisas 支持哪些平台？
Eisas 跨平台运行，可在任意部署了 OpenClaw / Claude Code 的环境中使用（cross-platform）。
谁开发了 Eisas？
由 hanxueyuan（@hanxueyuan）开发并维护，当前版本 v1.0.0。
推荐 Skills